84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Biotechnology Market Anticipates Soaring to a Staggering USD 3,672.9 Billion by 2032 || Market.us
08 janv. 2024 07h32 HE | Market.Us
New York, Jan. 08, 2024 (GLOBE NEWSWIRE) -- According to the market.us, the global Biotechnology market witnessed a valuation of USD 1023.8 Billion in 2022. Projections indicate a significant...
New Logo- Pls use this for all on going release.jpg
Green Star Products Issues a Force Majeure
05 janv. 2022 09h30 HE | Green Star Products, Inc
SALT LAKE CITY, UT, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Today, Ms. Kristy Hunt President of Green Star Products, Inc. (US OTC: GSPI), stated that on December 28, 2021, Green Star Products issued a...
Shineco New Logo.png
Shineco, Inc. Announces Entering Into a Securities Purchase Agreement with GHS Investments, LLC with Gross Proceeds of $2.0 Million USD
06 déc. 2021 16h15 HE | Shineco, Inc.
BEIJING, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech...
GSPI logo.jpg
Green Star Products: Ready to Close COVID-19 Contract at Shareholders Meeting
26 févr. 2021 06h30 HE | Green Star Products, Inc
SALT LAKE CITY, UT, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Today, Mr. Joseph LaStella, President of Green Star Products, Inc. (USOTC: GSPI) stated, “The Company has enough early votes to close the...
GSPI logo.jpg
Green Star Products Signs Covid-19 Distribution Contract
14 déc. 2020 09h30 HE | Green Star Products, Inc
SALT LAKE CITY, UT, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Last Friday, December 11, 2020, Joseph LaStella, President of Green Star Products, Inc. (OTC: GSPI) announced he signed a Distribution Contract...
energias.jpg
Global Marine Biotechnology Market to Witness a CAGR of 9.61% during 2018-2024
04 mars 2019 06h51 HE | Energias Market Research
NEW YORK, March 04, 2019 (GLOBE NEWSWIRE) -- The global marine biotechnology market is expected to grow significantly from USD 3,500.4 million in 2017 to USD 6,500.6 million in 2024, at a CAGR of...
Beleave Strengthens
Beleave Strengthens Advisory Board With Addition of Andrew Steane
03 mai 2016 10h54 HE | Beleave Inc.
TORONTO, May 03, 2016 (GLOBE NEWSWIRE) -- Beleave Inc. (CSE:BE) (“Beleave” or the “Company”) is pleased to announce that Andrew Steane will be added to the company’s Advisory Board. With over 20...
FEI Partners with Fi
FEI Partners with Five Pharmaceutical Companies, the Medical Research Council and the University of Cambridge to form Cryo-EM Research Consortium 
04 avr. 2016 06h05 HE | FEI Company
HILLSBORO, Ore. and LONDON, April 04, 2016 (GLOBE NEWSWIRE) -- FEI (NASDAQ:FEIC) has partnered with five pharmaceutical companies: Astex Pharmaceuticals, AstraZeneca, GlaxoSmithKline, Heptares...